New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 30, 2014
06:07 EDTPSTIPluristem Therapeutics awarded $4.2M grant by Israeli Go
Pluristem Therapeutics announced that its wholly owned subsidiary, Pluristem Ltd., has received approval for an approximately $4.2M grant from the Office of the Chief Scientist within the Israeli Ministry of Economy. Once received, the grant will be used to cover R&D expenses for the period January to December.
News For PSTI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
09:52 EDTPSTIPluristem raises $17M in a registered direct offering
Subscribe for More Information
June 24, 2015
05:30 EDTPSTIPluristem granted Australian patent for 3D cell expansion technology
Pluristem Therapeutics announced that it has been granted an Australian patent titled "Adherent Cells From Placenta Tissue and Use Thereof in Therapy". Patent #2009288781 covers Pluristem's proprietary, three-dimensional method of growing cells from placental or adipose tissue, cells produced by the process, and the use of such cells in the potential treatment of a broad range of conditions. These include peripheral artery disease, other ischemic and cardiovascular diseases, graft-versus-host disease, organ transplantation, cancer, and autoimmune diseases. The patent term will extend until 2027.
June 17, 2015
05:36 EDTPSTIPluristem awarded $2.9M grant by Israeli Government
Pluristem Therapeutics announced that its wholly owned subsidiary, Pluristem Ltd., has been awarded approximately $2.9M from the Office of the Chief Scientist of the Israeli Ministry of Economy. The grant will support R&D activities for calendar year 2015.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use